Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 5/2016

01-05-2016 | Original Article – Cancer Research

Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany

Authors: M. Bade, V. Bähr, U. Brandt, A. Eigentopf, T. Brüchert, M.-L. Gross, E. Motsch, N. Becker

Published in: Journal of Cancer Research and Clinical Oncology | Issue 5/2016

Login to get access

Abstract

Introduction

In the German lung cancer screening trial LUSI, smoking cessation counseling (SCC) was offered to all participants at time of randomization, and smoking habits were asked for within annual questionnaire inquiries. We analyzed the smoking habits of the participants within the first 2 years of follow-up and especially the potential effect of the SCC on these habits.

Materials and methods

We used the smoking data of the initial inquiry on which the decision on invitation to the study was based, the socio-economic data of the questionnaire filled-in at time of randomization, the psycho-social data obtained during the SCC, and the annual questionnaire data of the first two annual follow-up screening rounds.

Results

Smoking prevalence decreased in the entire cohort significantly by 4 %, whereby the decrease was with 4.5 % statistically not significantly higher in the control arm than in the screening arm with 3.4 %. The decline was much stronger in the subgroup of attendees to stop-smoking counseling and mounted up therein to 10 %. In some participants, an increase of readiness to quit smoking was observed during the counseling hour, but did not show effects on smoking status 2 years later.

Discussion

We did not see a tendency to increased smoking among participants of the intervention arm or the entire study. The decline of smoking prevalence among the attendees of the counseling might be due to self-selection. Since the issue of effectiveness of smoking cessation counseling is important, further research with randomization into offering counseling or no intervention should be taken into consideration.
Literature
go back to reference Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M (2009) Effect of CT screening on smoking habits at 1 year follow-up in the Danish lung cancer screening trial (DLCST). Thorax 64:388–392. doi:10.1136/thx.2008.102475 CrossRefPubMed Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M (2009) Effect of CT screening on smoking habits at 1 year follow-up in the Danish lung cancer screening trial (DLCST). Thorax 64:388–392. doi:10.​1136/​thx.​2008.​102475 CrossRefPubMed
go back to reference Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 12:159–182CrossRefPubMed Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 12:159–182CrossRefPubMed
go back to reference Flehinger BJ, Kimmel M, Melamed MR (1992) The effect of surgical treatment on survival from early lung cancer. Implic Screen Chest 101:1013–1018PubMed Flehinger BJ, Kimmel M, Melamed MR (1992) The effect of surgical treatment on survival from early lung cancer. Implic Screen Chest 101:1013–1018PubMed
go back to reference Lindinger P (2000) Die Rauchersprechstunde: Beratungskonzept für Gesundheitsberufe, vol 1. Rote Reihe Tabakprävention und Tabakkontrolle, Heidelberg Lindinger P (2000) Die Rauchersprechstunde: Beratungskonzept für Gesundheitsberufe, vol 1. Rote Reihe Tabakprävention und Tabakkontrolle, Heidelberg
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed
go back to reference Parsons LS (2004) Performing a 1: N case-control match on propensity score. In: Proceedings of the 29th annual SAS users group international conference. SUGI 29, SAS Institute Inc, Montreal, pp 165–29 Parsons LS (2004) Performing a 1: N case-control match on propensity score. In: Proceedings of the 29th annual SAS users group international conference. SUGI 29, SAS Institute Inc, Montreal, pp 165–29
go back to reference Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking. Toward an integrative model of change. J Consult Clin Psychol 51:390–395CrossRefPubMed Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking. Toward an integrative model of change. J Consult Clin Psychol 51:390–395CrossRefPubMed
go back to reference Ratitch B, Lipkovich I, O’Kelly M (2013) Combining analysis results from multiply imputed categorical data. In: PharmaSUG2013-Paper SP03. SAS Institute Inc Ratitch B, Lipkovich I, O’Kelly M (2013) Combining analysis results from multiply imputed categorical data. In: PharmaSUG2013-Paper SP03. SAS Institute Inc
go back to reference Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL (2009) Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomark Prev 18:3484–3489. doi:10.1158/1055-9965.EPI-09-0895 CrossRef Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL (2009) Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomark Prev 18:3484–3489. doi:10.​1158/​1055-9965.​EPI-09-0895 CrossRef
go back to reference Townsend CO et al (2005) Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 103:2154–2162. doi:10.1002/cncr.21045 CrossRefPubMed Townsend CO et al (2005) Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 103:2154–2162. doi:10.​1002/​cncr.​21045 CrossRefPubMed
go back to reference van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ (2010) Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial. Thorax 65:600–605. doi:10.1136/thx.2009.133751 CrossRefPubMed van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ (2010) Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial. Thorax 65:600–605. doi:10.​1136/​thx.​2009.​133751 CrossRefPubMed
Metadata
Title
Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany
Authors
M. Bade
V. Bähr
U. Brandt
A. Eigentopf
T. Brüchert
M.-L. Gross
E. Motsch
N. Becker
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 5/2016
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-2105-0

Other articles of this Issue 5/2016

Journal of Cancer Research and Clinical Oncology 5/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.